MAGNOLIA MEDICAL TECHNOLOGIES, INC.

MAGNOLIA MEDICAL TECHNOLOGIES, INC. specializes in the design and manufacturing of precision medical devices and in-vitro diagnostic reagents for clinical and laboratory use. The company develops and supplies blood culture collection systems, diagnostic test kits, and associated reagents that meet stringent regulatory standards for accuracy, sterility, and reliability in point-of-care and centralized lab environments. Their technical expertise lies in sterile manufacturing processes, diagnostic assay formulation, and medical device packaging compliant with FDA and CLIA requirements. A key differentiator is their ability to deliver mission-critical diagnostic consumables under tight regulatory and supply chain constraints, ensuring uninterrupted availability for high-volume clinical operations. The contractor has delivered products to the Department of Veterans Affairs and the Department of Health and Human Services, primarily supporting laboratory diagnostics and specimen collection infrastructure. For the VA, they provided in-vitro diagnostic test kits under a Federal Supply Schedule contract, indicating direct alignment with VA medical center testing needs. With HHS, they supplied blood culture collection devices and related supplies under a funded modification, demonstrating responsiveness to evolving public health and laboratory operational demands. Their primary industry focus is surgical and medical instrument manufacturing (NAICS 339112) and in-vitro diagnostic substance manufacturing (NAICS 325413), positioning them as a niche supplier of FDA-regulated diagnostic and procedural consumables. They serve the clinical diagnostics and public health sectors with products designed for integration into automated lab systems and frontline clinical workflows. MAGNOLIA MEDICAL TECHNOLOGIES, INC. is a small business headquartered in Seattle, Washington, with no federal certifications on record. Their geographic base supports access to Pacific Northwest biotech talent and logistics networks, enabling efficient distribution to federal medical facilities across the U.S. The company maintains a focused market presence in government healthcare procurement channels, emphasizing regulatory compliance and reliable supply chain performance.